The historic rise of Viagra has consistently remained a symbol of pharmaceutical success, but its here future within the broader sector now triggers questions about long-term gains. Generic versions are diminishing market share, prompting worries that supporting companies significantly dependent to Viagra's former position could be a dangerous deci